Company Name
Lepu Medical Technology (Beijing) Co., Ltd.
Legal Representative
Zhongjie Pu
General Manager
Zhibin Zhang
Accounting Firm
Lixin Certified Public Accountants (special general partnership)
Securities Representative
Jingjing Li
Legal Counsel
Beijing Deheng Law Firm
Office Address
No. 37 Chaoqian Road, Changping District, Beijing
Registered Address
No. 37 Chaoqian Road, Changping District, Beijing
Business License
110000410140103
Business
Technological development and production of medical devices and their accessories; sale of self-produced products; provision of technical consulting services for self-produced products; import and export of the above products; technology import and export; commission agency (excluding auctions; goods involving quotas, license management, and special regulations are handled in accordance with relevant national regulations)
Description
Lepu (Beijing) Medical Devices Co., Ltd. was founded in 1999. It is a listed joint stock group company. The company's sales network covers all over China and 95 countries and regions, with annual revenue of 4.6 billion yuan. By adhering to the development path of technological innovation, quality leadership, and win-win cooperation, Lepu Medical Group is striving to establish a four-in-one platform enterprise for the entire cardiovascular industry chain. The company is mainly engaged in R&D, production and sales of medical devices and pharmaceuticals related to pan-cardiovascular diseases, and is committed to building an integrated platform for medical devices, pharmaceuticals, medical services and health management in the pan-cardiovascular field. The company's main coronary implant products include traditional metal stent system products, degradable stents, drug balloons, cut balloons and vascular access products. Congenital heart disease. The main products include atrial septal defects, ventricular septal defects, and unoccluded arterial catheters. Cardiogenic stroke mainly includes left atrial ear blocker and unsealed ovary products. Valvular disease. Currently, clinical-stage products include the transcatheter implantable aortic valve system SimoCrown, the transmitral mitral valve repair system (tendon cord), and the transapical mitral valve clip repair system.
